FDA Inspection 1204020 — High Point Regional Health System
The FDA completed an inspection of High Point Regional Health System on April 26, 2023 in High Point, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 26, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- High Point, NC (United States)